HK Stock Market Move | CHINAHONGQIAO(01378) rises by more than 6% to continue to hit new highs. Citigroup predicts that the aluminum industry's gross profit will remain high in the long term. The company's dividend yield still remains attractive.
China Hongqiao (01378) rose more than 6% in early trading, reaching a high of HK$31.44, continuing to hit a record high. As of the time of writing, it has risen 5.36% to HK$31.08, with a trading volume of 2.63 billion Hong Kong dollars.
CHINAHONGQIAO (01378) rose more than 6% in early trading, reaching a high of HK$31.44, continuing to set new historical highs. As of the time of writing, it has risen by 5.36% to HK$31.08, with a turnover of HK$263 million.
Citi released a research report stating that the aluminum industry is still one of Citi's favorite industries, as the bank expects aluminum supply to remain tight. This is due to China's capacity cap policy (annual capacity of 45.2 million tons) and the absence of explosive capacity increases in Indonesia, resulting in high aluminum industry gross margins in the long term. Citi has raised its profit forecasts for CHINAHONGQIAO for 2025/26/27 by +2%/+5%/+7% respectively to RMB 24.4 billion/27.9 billion/30.3 billion, reflecting higher aluminum and alumina sales volumes and higher aluminum price forecasts.
It is worth noting that the company is focused on maintaining a high dividend payout ratio and share buybacks for shareholder returns. Despite the strong performance of the stock price so far this year, as of the close on November 4th, Hongqiao's forecast dividend yield for 2026 remains attractive at 6.7%. Citi expects Hongqiao to continue benefiting from high aluminum industry gross margins in the long term, and the stock will continue to be revalued. They maintain a "buy" rating on CHINAHONGQIAO and have raised their target price from HK$25.2 to HK$36, with Hongqiao as their top pick.
Related Articles

Leading the way in advancing the influenza vaccine, AB&B BIO-TECH-B (02627) is expected to fill the gap in the maternal and child vaccine market.

Soochow: Resilience of beer demand in 2024 still exists, focus on scene repair in 2025.

HK Stock Market Move | Chinese brokerage stocks rebounded today. The performance of the top three listed brokerages in the first three quarters of the year has seen a significant increase. Brokerage and investment businesses are the core drivers.
Leading the way in advancing the influenza vaccine, AB&B BIO-TECH-B (02627) is expected to fill the gap in the maternal and child vaccine market.

Soochow: Resilience of beer demand in 2024 still exists, focus on scene repair in 2025.

HK Stock Market Move | Chinese brokerage stocks rebounded today. The performance of the top three listed brokerages in the first three quarters of the year has seen a significant increase. Brokerage and investment businesses are the core drivers.

RECOMMEND

Starbucks China Transaction: Aggressive Expansion, the South Korea Precedent, and Persistent Core Challenges
05/11/2025

Supor’s Slowdown: Profit Plunge, Executive Share Sales, and Challenges Under Foreign Control
05/11/2025

Central Bank Resumes Bond Trading and Launches ¥700 Billion Outright Reverse Repo
05/11/2025


